Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600976.SS Stock Summary
In the News
600976.SS Financial details
Company Rating
Strong Buy
Market Cap
8.17B
Income
521.46M
Revenue
4.21B
Book val./share
14.69
Cash/share
6.53
Dividend
1
Dividend %
1.6%
Employees
2.25K
Optionable
No
Shortable
Yes
Earnings
18 Apr 2024
P/E
19.1
Forward P/E
11.64
PEG
6.57
P/S
2.48
P/B
4.44
P/C
8.8
P/FCF
85.95
Quick Ratio
1.29
Current Ratio
1.5
Debt / Equity
0.22
LT Debt / Equity
0.01
-
-
EPS (TTM)
3.42
EPS next Y
4.94
EPS next Q
-
EPS this Y
28.68%
EPS next Y
44.52%
EPS next 5Y
76.32%
EPS last 5Y
41.55%
Revenue last 5Y
13.32%
Revenue Q/Q
13.85%
EPS Q/Q
-34.58%
-
-
-
-
SMA20
-1.86%
SMA50
-15.03%
SMA100
-7.65%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
25%
ROC
0.27%
Gross Margin
47%
Oper. Margin
15%
Profit Margin
13%
Payout
31%
Shs Outstand
153M
Shs Float
105.53M
-
-
-
-
Target Price
-
52W Range
42.24-84.93
52W High
-31.56%
52W Low
+36.88%
RSI
57.11
Rel Volume
1.12
Avg Volume
2.43M
Volume
2.72M
Perf Week
5.06%
Perf Month
5.87%
Perf Quarter
-
Perf Half Y
-9.28%
-
-
-
-
Beta
0.662
-
-
Volatility
1.52%, 1.51%
Prev Close
3.03%
Price
57.49
Change
9.09%
600976.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 14.68 | 16.02 | 21.59 | 23.91 | 27.36 | |
Net income per share | 0.6 | 0.96 | 2.01 | 2.68 | 3.41 | |
Operating cash flow per share | 0.49 | 0.82 | 1.71 | 1.42 | 2.43 | |
Free cash flow per share | 0.03 | 0.52 | 1.34 | 0.97 | 2.01 | |
Cash per share | 3.12 | 3.76 | 5.51 | 5.65 | 6.54 | |
Book value per share | 7.88 | 8.59 | 10.28 | 12.23 | 14.7 | |
Tangible book value per share | 7.65 | 8.35 | 10.04 | 11.99 | 14.65 | |
Share holders equity per share | 7.88 | 8.59 | 10.28 | 12.23 | 14.7 | |
Interest debt per share | 0.35 | 0.13 | 0.4 | 0.38 | 3.31 | |
Market cap | 2.71B | 3.89B | 11.98B | 7.57B | 10.07B | |
Enterprise value | 2.62B | 3.82B | 11.74B | 7.4B | 10.26B | |
P/E ratio | 29.62 | 26.34 | 39.25 | 18.54 | 19.3 | |
Price to sales ratio | 1.21 | 1.59 | 3.65 | 2.08 | 2.41 | |
POCF ratio | 36.4 | 31.01 | 46.23 | 35.05 | 27.09 | |
PFCF ratio | 527.68 | 48.69 | 58.96 | 51.16 | 32.78 | |
P/B Ratio | 2.26 | 2.96 | 7.67 | 4.06 | 4.48 | |
PTB ratio | 2.26 | 2.96 | 7.67 | 4.06 | 4.48 | |
EV to sales | 1.17 | 1.56 | 3.58 | 2.03 | 2.45 | |
Enterprise value over EBITDA | 20.5 | 21.01 | 29.46 | 14.26 | 27.6 | |
EV to operating cash flow | 35.16 | 30.44 | 45.29 | 34.28 | 27.61 | |
EV to free cash flow | 509.75 | 47.8 | 57.78 | 50.04 | 33.42 | |
Earnings yield | 0.03 | 0.04 | 0.03 | 0.05 | 0.05 | |
Free cash flow yield | 0 | 0.02 | 0.02 | 0.02 | 0.03 | |
Debt to equity | 0.04 | 0.02 | 0.04 | 0.03 | 0.22 | |
Debt to assets | 0.03 | 0.01 | 0.02 | 0.02 | 0.12 | |
Net debt to EBITDA | -0.72 | -0.39 | -0.61 | -0.32 | 0.53 | |
Current ratio | 1.68 | 1.42 | 1.52 | 1.5 | 1.49 | |
Interest coverage | 157.65 | 293.66 | 112.72 | 91.94 | 64.87 | |
Income quality | 0.8 | 0.84 | 0.8 | 0.53 | 0.71 | |
Dividend Yield | 0.01 | 0.01 | 0 | 0.02 | 0.02 | |
Payout ratio | 0.34 | 0.21 | 0.19 | 0.3 | 0.29 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.93 | -0.36 | -0.22 | -0.31 | -0.17 | |
Capex to revenue | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | |
Capex to depreciation | -3.55 | -2.2 | -1.95 | -1.75 | -1.09 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0 | 0 | -0.05 | |
Graham number | 10.31 | 13.65 | 21.56 | 27.16 | 33.58 | |
ROIC | 0.08 | 0.11 | 0.2 | 0.21 | 0.1 | |
Return on tangible assets | 0.05 | 0.06 | 0.11 | 0.12 | 0.13 | |
Graham Net | 1.56 | 0.74 | 1.78 | 1.62 | 1.64 | |
Working capital | 472.36M | 445.44M | 633.41M | 771.06M | 908.95M | |
Tangible asset value | 1.17B | 1.28B | 1.52B | 1.83B | 2.24B | |
Net current asset value | 450.07M | 419.18M | 596.12M | 734.91M | 873.04M | |
Invested capital | 0.04 | 0.02 | 0.04 | 0.03 | 0.22 | |
Average receivables | 510.2M | 620.35M | 731M | 903.4M | 1.13B | |
Average payables | 219.27M | 306.49M | 374.08M | 491.68M | 507.21M | |
Average inventory | 147.61M | 181.73M | 225.37M | 292.31M | 406.86M | |
Days sales outstanding | 90.06 | 102.29 | 86.15 | 103.57 | 106.8 | |
Days payables outstanding | 64.36 | 94.1 | 73.35 | 107.99 | 63.94 | |
Days of inventory on hand | 36.5 | 57.33 | 43.69 | 64.13 | 71.47 | |
Receivables turnover | 4.05 | 3.57 | 4.24 | 3.52 | 3.42 | |
Payables turnover | 5.67 | 3.88 | 4.98 | 3.38 | 5.71 | |
Inventory turnover | 10 | 6.37 | 8.35 | 5.69 | 5.11 | |
ROE | 0.08 | 0.11 | 0.2 | 0.22 | 0.23 | |
Capex per share | -0.45 | -0.3 | -0.37 | -0.45 | -0.42 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.55 | 6.62 | 7.52 | 6.29 | 7.12 | |
Net income per share | 0.53 | 0.65 | 1 | 1.07 | 0.69 | |
Operating cash flow per share | 0.53 | 0.65 | 0.98 | 0.61 | 0.65 | |
Free cash flow per share | 0.36 | 0.57 | 0.87 | 0.54 | 0.49 | |
Cash per share | 5.64 | 7.02 | 5.6 | 6.05 | 6.53 | |
Book value per share | 12.22 | 12.82 | 12.91 | 14.05 | 14.69 | |
Tangible book value per share | 11.97 | 12.57 | 12.66 | 13.82 | 14.65 | |
Share holders equity per share | 12.22 | 12.82 | 12.91 | 14.05 | 14.69 | |
Interest debt per share | 0.36 | 0.71 | 0.81 | 0.84 | 3.28 | |
Market cap | 7.58B | 11.71B | 11.76B | 10.07B | 10.07B | |
Enterprise value | 7.41B | 11.45B | 11.49B | 10.07B | 10.27B | |
P/E ratio | 23.26 | 29.41 | 19.24 | 15.47 | 23.68 | |
Price to sales ratio | 8.96 | 11.56 | 10.25 | 10.53 | 9.25 | |
POCF ratio | 93.02 | 117.63 | 79.03 | 107.9 | 100.8 | |
PFCF ratio | 137.04 | 134.32 | 88.6 | 123.6 | 133.01 | |
P/B Ratio | 4.07 | 5.96 | 5.97 | 4.72 | 4.48 | |
PTB ratio | 4.07 | 5.96 | 5.97 | 4.72 | 4.48 | |
EV to sales | 8.76 | 11.3 | 10.01 | 10.53 | 9.43 | |
Enterprise value over EBITDA | 55.49 | 112.75 | 63.1 | 64.7 | 147.03 | |
EV to operating cash flow | 90.98 | 115.04 | 77.17 | 107.92 | 102.76 | |
EV to free cash flow | 134.04 | 131.37 | 86.52 | 123.62 | 135.6 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0.03 | 0.06 | 0.06 | 0.06 | 0.22 | |
Debt to assets | 0.02 | 0.03 | 0.03 | 0.03 | 0.12 | |
Net debt to EBITDA | -1.24 | -2.53 | -1.52 | 0.01 | 2.81 | |
Current ratio | 1.5 | 1.64 | 1.47 | 1.5 | 1.49 | |
Interest coverage | 102.36 | 2.4K | 202.7 | 128.66 | 37.1 | |
Income quality | 1 | 1 | 0.97 | 0.57 | 0.94 | |
Dividend Yield | 0 | 0 | 0.01 | 0 | 0.02 | |
Payout ratio | 0.01 | 0 | 1 | 0.01 | 1.44 | |
Sales general and administrative to revenue | -0.08 | 0.04 | -0.02 | 0.12 | -0.09 | |
Research and developement to revenue | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.32 | -0.12 | -0.11 | -0.13 | -0.24 | |
Capex to revenue | -0.03 | -0.01 | -0.01 | -0.01 | -0.02 | |
Capex to depreciation | -1.57 | -0.96 | -1.25 | 0.66 | -1.45 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Graham number | 12.12 | 13.69 | 17.06 | 18.4 | 15.16 | |
ROIC | 0.07 | 0.05 | 0.07 | 0.07 | 0.02 | |
Return on tangible assets | 0.02 | 0.03 | 0.04 | 0.04 | 0.03 | |
Graham Net | 1.62 | 3.22 | 1.59 | 1.87 | 1.64 | |
Working capital | 771.06M | 1.06B | 790.73M | 859.98M | 908.95M | |
Tangible asset value | 1.83B | 1.92B | 1.93B | 2.1B | 2.24B | |
Net current asset value | 734.91M | 1.02B | 749.53M | 806.38M | 873.04M | |
Invested capital | 0.03 | 0.06 | 0.06 | 0.06 | 0.22 | |
Average receivables | 1.09B | 1.14B | 1.26B | 1.28B | 1.26B | |
Average payables | 578.13M | 611.68M | 596.63M | 596.85M | 508.04M | |
Average inventory | 270.15M | 355.02M | 325.93M | 317.44M | 390.51M | |
Days sales outstanding | 109.92 | 111.35 | 99.1 | 122.01 | 101.21 | |
Days payables outstanding | 118.56 | 108.02 | 80.68 | 113.11 | 56.93 | |
Days of inventory on hand | 70.41 | 61.24 | 42.31 | 60.95 | 63.63 | |
Receivables turnover | 0.82 | 0.81 | 0.91 | 0.74 | 0.89 | |
Payables turnover | 0.76 | 0.83 | 1.12 | 0.8 | 1.58 | |
Inventory turnover | 1.28 | 1.47 | 2.13 | 1.48 | 1.41 | |
ROE | 0.04 | 0.05 | 0.08 | 0.08 | 0.05 | |
Capex per share | -0.17 | -0.08 | -0.11 | -0.08 | -0.16 |
600976.SS Frequently Asked Questions
What is Jianmin Pharmaceutical Group Co.,Ltd. stock symbol ?
Jianmin Pharmaceutical Group Co.,Ltd. is a CN stock and trading under the symbol 600976.SS
What is Jianmin Pharmaceutical Group Co.,Ltd. stock quote today ?
Jianmin Pharmaceutical Group Co.,Ltd. stock price is $57.49 today.
Is Jianmin Pharmaceutical Group Co.,Ltd. stock public?
Yes, Jianmin Pharmaceutical Group Co.,Ltd. is a publicly traded company.